Anti-TNF therapy-induced lupus erythematosus-like syndrome in a patient treated with adalimumab for cutaneous psoriasis.

Stein, Julie E; Patterson-Fortin, Jeffrey; Bodnar, Benjamin E

Stein, Julie E; Patterson-Fortin, Jeffrey; Bodnar, Benjamin E.

Affiliation

Stein JE; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Patterson-Fortin J; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Bodnar BE; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

BMJ Case Rep ; 20182018 Apr 13.

Article in En | MEDLINE | ID: mdl-29654101

Subject(s)

Adalimumab/adverse effects; Antirheumatic Agents/adverse effects; Lupus Erythematosus, Systemic/chemically induced; Psoriasis/drug therapy; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Adalimumab/administration & dosage; Administration, Cutaneous; Adult; Antirheumatic Agents/administration & dosage; Female; Humans; Lupus Erythematosus, Systemic/drug therapy; Prednisone/administration & dosage

Key words

dermatology; immunological products and vaccines; musculoskeletal syndromes; systemic lupus erythematosus

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Tumor Necrosis Factor-alpha / Antirheumatic Agents / Adalimumab / Lupus Erythematosus, Systemic Limits: Adult / Female / Humans Language: En Journal: BMJ Case Rep Year: 2018 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google